SBC MEDICAL GROUP HOLDINGS I
SBCNASDAQTrading Snapshot
- Day Range
- $5.03 โ $5.48
- 52-Week Range
- $2.78 โ $7.39
- Volume (shares)
- 18,967
- Avg Volume (shares)
- โ
- Shares Outstanding
- 102.8M
- Next Earnings
- 2027-03-25
Fundamentals Snapshot
- Annual Revenue
- $174M
- Last Q Revenue
- $59M
- P/E Ratio
- 10.3
- P/S Ratio
- 2.8x
- EPS (TTM)
- $0.51
- Dividend Yield
- 0.00%
SBC MEDICAL GROUP HOLDINGS I
SBCFinancial history unavailable.
About SBC MEDICAL GROUP HOLDINGS I
SBC Medical Group Holdings Incorporated provides comprehensive operational support to aesthetic and cosmetic clinics across a global footprint, including Japan, Vietnam, the United States, and other international markets. The company delivers a diverse array of administrative and support functions, such as orchestrating marketing and advertising campaigns, offering extensive human resources solutions including talent acquisition and staff training, and streamlining appointment scheduling for franchisee clinics. Furthermore, SBC Medical Group facilitates real estate arrangements for both employee housing and clinic facility rentals, oversees the design and construction of new clinics, and manages the procurement of essential medical equipment and supplies. Additionally, the firm furnishes IT software solutions. The broad spectrum of aesthetic and reconstructive procedures facilitated by SBC Medical Group's supported clinics encompasses both surgical and non-surgical interventions. These include popular treatments such as breast augmentation, liposuction, and various rejuvenation therapies targeting wrinkles, acne, scars, and signs of aging. The offerings also extend to specialized procedures like laser skin toning, double fold eye surgery, rhinoplasty, hair transplants, laser hair removal, cosmetic dental work, tattoo removal, and advanced eye procedures like LASIK, among others. Established in 2000, SBC Medical Group Holdings Incorporated maintains its headquarters in Irvine, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1โ5โ and equally weighted (20%), averaged to a 0โ100 score:๐ Quality โ gross margin๐ Growth โ revenue YoYโ๏ธ Valuation โ P/S ratioโก Momentum โ 30-day price change๐ง Dilution โ 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Analyst Ratings
โLatest News & Updates
News unavailable.